1st Quarter - Report

RICCHETTI INCORPORATED for BOSTON SCIENTIFIC CORPORATION

Firm
Client
Income
$15,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Consumer Issues/Safety/Products CSP

issues related to FDA medical device user fees

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Regulatory and reimbursement issues for medical devices in Medicare Implementation of coverage, coding and reimbursement under the 2003 Medicare Prescription Drug Improvement and Modernization Act HR 3162 Children's Health and Medicare Protection Act of 2007 Medicare payment of inpatient hospital services S. 631 Remote Monitoring Access Act of 2007 Medicare clinical research policy S. 2029 Physician Payments Sunshine Act S. 2221 Transparency Medical Device Pricing Act comparative effectiveness research

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2029 (110th), S. 631 (110th), H.R. 3162 (110th), S. 2221 (110th)

Health Issues HCR

H.R. 1494 Pediatric Medical Device Safety and Improvement Act of 2007 Issues relating to disclosure of payments to providers Issues relating to the implementation of MDUFMA Issues relating to CHAMP Act

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1494 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.